JP2021524480A5 - - Google Patents
Info
- Publication number
- JP2021524480A5 JP2021524480A5 JP2021500106A JP2021500106A JP2021524480A5 JP 2021524480 A5 JP2021524480 A5 JP 2021524480A5 JP 2021500106 A JP2021500106 A JP 2021500106A JP 2021500106 A JP2021500106 A JP 2021500106A JP 2021524480 A5 JP2021524480 A5 JP 2021524480A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- substituted
- pharmaceutically acceptable
- alkyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305911.2 | 2018-07-09 | ||
| EP18305911.2A EP3594205A1 (en) | 2018-07-09 | 2018-07-09 | Phenyl-n-aryl derivatives for treating a rna virus infection |
| PCT/EP2019/068460 WO2020011811A1 (en) | 2018-07-09 | 2019-07-09 | Aryl-n-aryl derivatives for treating a rna virus infection |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021524480A JP2021524480A (ja) | 2021-09-13 |
| JPWO2020011811A5 JPWO2020011811A5 (https=) | 2022-06-22 |
| JP2021524480A5 true JP2021524480A5 (https=) | 2022-06-22 |
| JP7541302B2 JP7541302B2 (ja) | 2024-08-28 |
Family
ID=63035967
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500577A Active JP7634847B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のアリール－ｎ－アリール誘導体 |
| JP2021500106A Active JP7541302B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のアリール－ｎ－アリール誘導体 |
| JP2021500268A Active JP7491513B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のアリール－ｎ－アリール誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500577A Active JP7634847B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のアリール－ｎ－アリール誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500268A Active JP7491513B2 (ja) | 2018-07-09 | 2019-07-09 | Ｒｎａウィルス感染を処置する為のアリール－ｎ－アリール誘導体 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US12421206B2 (https=) |
| EP (4) | EP3594205A1 (https=) |
| JP (3) | JP7634847B2 (https=) |
| KR (3) | KR102905375B1 (https=) |
| CN (3) | CN112703183B (https=) |
| AU (3) | AU2019300101A1 (https=) |
| BR (3) | BR112021000323A2 (https=) |
| CA (3) | CA3104228A1 (https=) |
| CU (3) | CU24667B1 (https=) |
| CY (1) | CY1126466T1 (https=) |
| DK (1) | DK3820849T3 (https=) |
| ES (1) | ES2965067T3 (https=) |
| FI (1) | FI3820849T3 (https=) |
| HR (1) | HRP20231571T1 (https=) |
| HU (1) | HUE064304T2 (https=) |
| LT (1) | LT3820849T (https=) |
| MX (3) | MX2021000086A (https=) |
| PL (1) | PL3820849T3 (https=) |
| PT (1) | PT3820849T (https=) |
| RS (1) | RS64949B1 (https=) |
| SI (1) | SI3820849T1 (https=) |
| WO (3) | WO2020011812A1 (https=) |
| ZA (3) | ZA202100141B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018165520A1 (en) | 2017-03-10 | 2018-09-13 | Vps-3, Inc. | Metalloenzyme inhibitor compounds |
| HUE066072T2 (hu) * | 2019-07-19 | 2024-07-28 | Abivax | Aril-N-aril-származékok RNS vírus fertõzés kezelésére |
| AU2020321955A1 (en) | 2019-07-30 | 2022-03-17 | Eikonizo Therapapeutics, Inc. | HDAC6 inhibitors and uses thereof |
| EP4125845A4 (en) * | 2020-04-02 | 2024-05-15 | Southern Research Institute | NEW 2-PYRIMIDONE ANALOGUES AS EFFECTIVE ANTIVIRAL AGENTS AGAINST ALPHAVIRES |
| CN118324717A (zh) * | 2020-11-24 | 2024-07-12 | 中国人民解放军海军军医大学 | 一类取代苯甲酰哌嗪类化合物及在制备抗基孔肯雅病毒药物中的应用 |
| JP2024506858A (ja) | 2021-02-02 | 2024-02-15 | リミナル・バイオサイエンシーズ・リミテッド | Ｇｐｒ８４アンタゴニストおよびその使用 |
| WO2022195522A1 (en) * | 2021-03-17 | 2022-09-22 | Ildong Pharmaceutical Co., Ltd. | Inhibitors of ano6 and their uses thereof |
| IL316201A (en) | 2022-04-08 | 2024-12-01 | Eikonizo Therapeutics Inc | Oxadiazole HDAC6 inhibitors and their uses |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070244120A1 (en) | 2000-08-18 | 2007-10-18 | Jacques Dumas | Inhibition of raf kinase using substituted heterocyclic ureas |
| US7429599B2 (en) * | 2000-12-06 | 2008-09-30 | Signal Pharmaceuticals, Llc | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| FR2830862A1 (fr) | 2001-10-16 | 2003-04-18 | Lipha | Derives nitroso de la diphenylamine a fonction ether ou thioether, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments |
| FR2836917B1 (fr) | 2002-03-11 | 2006-02-24 | Lipha | Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant en tant que medicaments utilisables dans le traitement des pathologies caracterisees par une situation de stress oxydatif |
| DE602004020073D1 (de) * | 2003-08-21 | 2009-04-30 | Osi Pharm Inc | 3-substituierte imidazopyridinderivate als c-kit-inhibitoren |
| FR2859474B1 (fr) | 2003-09-04 | 2006-01-13 | Centre Nat Rech Scient | Utilisation de composes derives d'indole pour la preparation d'un medicament utile pour le traitement de maladies genetiques resultant de l'alteration des processus d'epissage |
| EP1697343B1 (en) | 2003-12-18 | 2009-07-01 | Tibotec Pharmaceuticals Ltd. | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| FR2866647B1 (fr) | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2006037117A1 (en) * | 2004-09-27 | 2006-04-06 | Amgen Inc. | Substituted heterocyclic compounds and methods of use |
| ES2574670T3 (es) | 2005-03-17 | 2016-06-21 | Janssen Sciences Ireland Uc | 1,3-Dihidro-bencimidazol-2-ilidenoaminas como inhibidores de replicación del virus sincicial respiratorio |
| US9409856B2 (en) | 2005-11-28 | 2016-08-09 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
| CN101443334A (zh) * | 2005-12-21 | 2009-05-27 | 艾博特公司 | 抗病毒化合物 |
| ATE475660T1 (de) | 2005-12-21 | 2010-08-15 | Abbott Lab | Antivirale verbindungen |
| US7915411B2 (en) | 2005-12-21 | 2011-03-29 | Abbott Laboratories | Anti-viral compounds |
| FR2901273B1 (fr) * | 2006-05-19 | 2010-12-24 | Anaconda Pharma | Inhibiteurs du virus du papillome humain et les compositions pharmaceutiques les contenant |
| JP4486667B2 (ja) * | 2007-10-01 | 2010-06-23 | 株式会社沖データ | 媒体搬送装置及び画像形成装置 |
| FR2926297B1 (fr) * | 2008-01-10 | 2013-03-08 | Centre Nat Rech Scient | Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage. |
| US8117648B2 (en) * | 2008-02-08 | 2012-02-14 | Intersections, Inc. | Secure information storage and delivery system and method |
| US20140187641A1 (en) * | 2012-08-23 | 2014-07-03 | Gtx | Estrogen receptor ligands and methods of use thereof |
| SI2440547T1 (sl) * | 2009-06-12 | 2023-05-31 | Abivax | Nove kemične molekule, ki zavirajo mehanizem spajanja za zdravljenje bolezni, ki so posledica napak pri spajanju |
| JP2011026251A (ja) | 2009-07-27 | 2011-02-10 | Kowa Co | ２−アリールアミノキノリン化合物及びこれを有効成分として含有するエリスロポエチン産生促進剤 |
| US8846713B2 (en) | 2010-06-24 | 2014-09-30 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors |
| EP2465502A1 (en) | 2010-12-15 | 2012-06-20 | Société Splicos | Compounds useful for treating AIDS |
| FR2972719B1 (fr) * | 2011-03-15 | 2013-04-12 | Gaztransp Et Technigaz | Bloc isolant pour la fabrication d'une paroi de cuve etanche |
| EP2505198A1 (en) * | 2011-04-01 | 2012-10-03 | Société Splicos | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
| EP2712862A1 (en) * | 2012-09-28 | 2014-04-02 | Splicos | New anti-invasive compounds |
| WO2014164667A1 (en) | 2013-03-11 | 2014-10-09 | Georgetown University | Dengue and west nile virus protease inhibitors |
| CA2916623C (en) * | 2013-07-05 | 2021-09-14 | Abivax | Bicyclic compounds useful for treating diseases caused by retroviruses |
| WO2015028989A1 (en) * | 2013-09-02 | 2015-03-05 | Actelion Pharmaceuticals Ltd | Novel heterocyclic compounds as antimalarial agents |
| RU2628800C2 (ru) | 2014-03-12 | 2017-08-22 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами |
| KR102265277B1 (ko) * | 2014-04-11 | 2021-06-16 | 판옵테스 파르마 게스.엠.베.하. | 바이러스 억제 화합물로서의 항-염증제 |
| US20160143884A1 (en) * | 2014-11-26 | 2016-05-26 | Esanex, Inc. | Use of tetrahydroindazolylbenzamide and tetrahydroindolylbenzamide derivatives for the treatment of human immunodeficiency virus (hiv) and acquired immune deficiency syndrome (aids) |
| EP3059591A1 (en) | 2015-02-23 | 2016-08-24 | Abivax | Methods for screening compounds for treating or preventing a viral infection or a virus-related condition |
| EP3058940A1 (en) | 2015-02-23 | 2016-08-24 | Abivax | Quinoline derivatives for use in the treatment or prevention of viral infection |
| PT3429998T (pt) | 2016-03-18 | 2021-11-04 | Prosynergia S A R L | Processo para preparação de derivados de quinolin-2-il-fenilamina e seus sais |
-
2018
- 2018-07-09 EP EP18305911.2A patent/EP3594205A1/en not_active Ceased
-
2019
- 2019-07-09 HU HUE19742312A patent/HUE064304T2/hu unknown
- 2019-07-09 CN CN201980045933.3A patent/CN112703183B/zh active Active
- 2019-07-09 CN CN201980045913.6A patent/CN112638877B/zh active Active
- 2019-07-09 PT PT197423122T patent/PT3820849T/pt unknown
- 2019-07-09 EP EP19742313.0A patent/EP3820850B1/en active Active
- 2019-07-09 EP EP19742312.2A patent/EP3820849B1/en active Active
- 2019-07-09 CA CA3104228A patent/CA3104228A1/en active Pending
- 2019-07-09 KR KR1020217001300A patent/KR102905375B1/ko active Active
- 2019-07-09 CU CU2021000007A patent/CU24667B1/es unknown
- 2019-07-09 AU AU2019300101A patent/AU2019300101A1/en active Pending
- 2019-07-09 CN CN201980045893.2A patent/CN112638876B/zh active Active
- 2019-07-09 CA CA3103353A patent/CA3103353A1/en active Pending
- 2019-07-09 AU AU2019300102A patent/AU2019300102B2/en active Active
- 2019-07-09 WO PCT/EP2019/068461 patent/WO2020011812A1/en not_active Ceased
- 2019-07-09 JP JP2021500577A patent/JP7634847B2/ja active Active
- 2019-07-09 ES ES19742312T patent/ES2965067T3/es active Active
- 2019-07-09 BR BR112021000323-1A patent/BR112021000323A2/pt unknown
- 2019-07-09 KR KR1020217001299A patent/KR102791105B1/ko active Active
- 2019-07-09 LT LTEPPCT/EP2019/068461T patent/LT3820849T/lt unknown
- 2019-07-09 MX MX2021000086A patent/MX2021000086A/es unknown
- 2019-07-09 RS RS20231164A patent/RS64949B1/sr unknown
- 2019-07-09 MX MX2021000095A patent/MX2021000095A/es unknown
- 2019-07-09 US US17/259,451 patent/US12421206B2/en active Active
- 2019-07-09 BR BR112021000298-7A patent/BR112021000298A2/pt unknown
- 2019-07-09 JP JP2021500106A patent/JP7541302B2/ja active Active
- 2019-07-09 KR KR1020217000560A patent/KR102827151B1/ko active Active
- 2019-07-09 HR HRP20231571TT patent/HRP20231571T1/hr unknown
- 2019-07-09 EP EP19742311.4A patent/EP3820848A1/en active Pending
- 2019-07-09 WO PCT/EP2019/068460 patent/WO2020011811A1/en not_active Ceased
- 2019-07-09 PL PL19742312.2T patent/PL3820849T3/pl unknown
- 2019-07-09 US US17/259,483 patent/US11739073B2/en active Active
- 2019-07-09 CU CU2021000005A patent/CU24703B1/es unknown
- 2019-07-09 AU AU2019300106A patent/AU2019300106B2/en active Active
- 2019-07-09 CU CU2021000004A patent/CU24640B1/es unknown
- 2019-07-09 WO PCT/EP2019/068465 patent/WO2020011816A1/en not_active Ceased
- 2019-07-09 JP JP2021500268A patent/JP7491513B2/ja active Active
- 2019-07-09 FI FIEP19742312.2T patent/FI3820849T3/fi active
- 2019-07-09 MX MX2021000090A patent/MX2021000090A/es unknown
- 2019-07-09 CA CA3103882A patent/CA3103882A1/en active Pending
- 2019-07-09 BR BR112021000336-3A patent/BR112021000336A2/pt unknown
- 2019-07-09 DK DK19742312.2T patent/DK3820849T3/da active
- 2019-07-09 US US17/259,370 patent/US12247018B2/en active Active
- 2019-07-09 SI SI201930676T patent/SI3820849T1/sl unknown
-
2021
- 2021-01-08 ZA ZA2021/00141A patent/ZA202100141B/en unknown
- 2021-01-08 ZA ZA2021/00143A patent/ZA202100143B/en unknown
- 2021-01-08 ZA ZA2021/00142A patent/ZA202100142B/en unknown
-
2023
- 2023-12-06 CY CY20231100718T patent/CY1126466T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021524480A5 (https=) | ||
| KR102326068B1 (ko) | 레트로바이러스에 의해 야기되는 질병 치료에 유용한 이고리 화합물 | |
| JP2021524481A5 (https=) | ||
| JP2004509113A5 (https=) | ||
| JP2021524482A5 (https=) | ||
| JP2004509114A5 (https=) | ||
| AR035979A1 (es) | Derivados de quinolina, procedimientos para su preparacion, composiciones farmaceuticas que los comprenden, y usos de dichos compuestos para la preparacion de medicament0s | |
| JP2005535586A5 (https=) | ||
| JP2016523893A5 (https=) | ||
| KR102905375B1 (ko) | Rna 바이러스 감염을 치료하기 위한 페닐/피리딜-n-페닐/피리딜 유도체 | |
| JP2002534519A5 (https=) | ||
| JP2004509118A5 (https=) | ||
| CA3025722A1 (en) | Combinations comprising histone deacetylase inhibitors | |
| JP2021524487A5 (https=) | ||
| JP2021500332A5 (https=) | ||
| JP2020533352A5 (https=) | ||
| CA2568608A1 (en) | Six membered amino-amide derivatives as angiogenesis inhibitors | |
| AU2013343291B2 (en) | Novel histone deacetylase inhibitors and their use in therapy | |
| JP2017532358A5 (https=) | ||
| JPWO2020011811A5 (https=) | ||
| CN1318056A (zh) | 用于治疗衰老相关性疾病和糖尿病性血管性并发症的新化合物,其制备方法,及其治疗用途 | |
| JP2005528459A5 (https=) | ||
| JP2003513066A5 (https=) | ||
| JP2006519807A5 (https=) | ||
| JP6689887B2 (ja) | 新規アミドヘテロアリールアロイルヒドラジドエチン |